Clemens Kevan 4
4 · Chelsea Therapeutics International, Ltd. · Filed Jan 13, 2011
Insider Transaction Report
Form 4
Clemens Kevan
Director
Transactions
- Award
Stock Option (Right to Buy)
2011-01-11+40,000→ 40,000 totalExercise: $7.72Exp: 2021-01-11→ Common Stock (40,000 underlying)
Holdings
- 5,000
Common Stock
- 40,000
Stock Option (Right to Buy)
Exercise: $2.96Exp: 2020-01-19→ Common Stock (40,000 underlying) - 40,000
Stock Option (Right to Buy)
Exercise: $1.78Exp: 2019-01-22→ Common Stock (40,000 underlying) - 42,500
Stock Option (Right to Buy)
Exercise: $6.50Exp: 2018-01-24→ Common Stock (42,500 underlying) - 42,500
Stock Option (Right to Buy)
Exercise: $5.68Exp: 2017-02-06→ Common Stock (42,500 underlying) - 30,000
Stock Option (Right to Buy)
Exercise: $3.26Exp: 2016-01-19→ Common Stock (30,000 underlying) - 35,210
Stock Option (Right to Buy)
Exercise: $0.20Exp: 2014-09-08→ Common Stock (35,210 underlying)
Footnotes (7)
- [F1]Option vests in four equal annual installments beginning on January 11, 2012.
- [F2]Option vests in four equal annual installments beginning on January 19, 2011.
- [F3]Option vests in four equal annual installments beginning on January 22, 2010.
- [F4]Option vests in four equal annual installments beginning on January 24, 2009.
- [F5]Option vests in four equal annual installments beginning on February 6, 2008.
- [F6]Option vests in four equal annual installments beginning on January 19, 2007.
- [F7]Option vested in two equal annual installments beginning on September 8, 2005.